Cortex Pharmaceuticals Inc.: The Irvine drug development...

Cortex Pharmaceuticals Inc.: The Irvine drug development company reported a net loss of $1.1 million, or 17 cents a share, for the second fiscal quarter ended Dec. 31, compared with a net loss of $1.6 million, or 27 cents a share, for the comparable quarter a year ago. No revenue was recorded. For the six-month period, a net loss of $2 million, or 33 cents a share, was posted, compared with a year-earlier net loss of $3.1 million, or 51 cents a share.